Panel on Excipient and Formulation Considerations

Автор: U.S. Food and Drug Administration

Загружено: 2020-11-23

Просмотров: 994

Описание:

Darby Kozak, Amanda Jones, Susan Zuk, and Yongcheng Huang answer audience questions.

Learn more at https://www.fda.gov/drugs/regulatory-...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2020 Playlist -    • 2020 CDER Small Business and Industry Assi...
SBIA LinkedIn -   / cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cderbsbialearn
Twitter -   / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367

Panel on Excipient and Formulation Considerations

Доступные форматы для скачивания:

Скачать видео mp4

Информация по загрузке:

Скачать аудио mp3

Похожие видео

In Vitro Studies for Alternative BE Approaches to Comparative Clinical Endpoint BE Studies

In Vitro Studies for Alternative BE Approaches to Comparative Clinical Endpoint BE Studies

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

Medical Device Quality Management System Regulation Risk Management

Medical Device Quality Management System Regulation Risk Management

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

SEND for CBER, What You Need to Know

SEND for CBER, What You Need to Know

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Catching Up on Agency Reforms

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA Direct: FDA Awards Six National Priority Vouchers

FDA Direct: FDA Awards Six National Priority Vouchers

Learn About ClinicalTrials.gov Modernization and How to Provide Input – Mar. 6, 2020

Learn About ClinicalTrials.gov Modernization and How to Provide Input – Mar. 6, 2020

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Medical Device Quality Management System Regulation Design and Development

Medical Device Quality Management System Regulation Design and Development

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

FDA Celebrates 120 Years

FDA Celebrates 120 Years